Olivier Taelman
Patrimonio netto: 37 634 $ in data 31/05/2026
Patrimonio netto: 37 634 $ in data 31/05/2026
Olivier Taelman currently works at Nyxoah SA, as Chief Executive Officer & Executive Director from 2020.
Mr. Taelman also formerly worked at Nevro Corp., as Business Director-Neuromodulation from 2013 to 2015 and Autonomic Technologies, Inc., as Vice President-Europe from 2015 to 2019.
Mr. Taelman received his undergraduate degree from Hasselt University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NYXOAH SA 0,01% | 01/03/2026 | 12.500 ( 0,01% ) | 37 634 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NYXOAH SA | Amministratore Delegato | 01/11/2019 |
| Società | Posizione | Fine |
|---|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Corporate Officer/Principal | 01/11/2019 |
| NEVRO CORP. | Corporate Officer/Principal | 01/12/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Health Technology |
Hasselt University
Hasselt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nevro Corp.
Nevro Corp. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nyxoah SA
Nyxoah SA Medical SpecialtiesHealth Technology Manufactures neurostimulation devices for treating obstructive sleep apnea | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale